WallStSmart
ADAG

Adagene Inc

NASDAQ: ADAG · HEALTHCARE · BIOTECHNOLOGY

$3.55
+0.57% today

Updated 2026-04-29

Market cap
$234.56M
P/E ratio
P/S ratio
30.58x
EPS (TTM)
$-0.37
Dividend yield
52W range
$1 – $5
Volume
0.3M

Adagene Inc (ADAG) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20182019202020212022202320242025
Revenue$1.51M$480000.00$480000.00$10.18M$9.29M$18.11M$103204.00$7.67M
Revenue growth (YoY)-68.2%+0.0%+2019.8%-8.7%+94.9%-99.4%+7332.8%
Cost of revenue$926248.00
Gross profit$1.51M$480000.00$480000.00$10.18M$9.29M$18.11M$-823044.00$7.67M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%-797.5%100.0%
R&D$16.08M$16.21M$16.21M$68.10M$81.34M$36.64M$28.78M$22.03M
SG&A$2.77M$3.44M$3.44M$14.44M$11.87M$8.67M$7.27M$7.08M
Operating income$-17.33M$-19.17M$-19.17M$-72.36M$-83.92M$-23.72M$-35.95M$-21.44M
Operating margin-1147.1%-3993.7%-3993.7%-711.2%-903.1%-131.0%-34835.4%-279.5%
EBITDA$-14.27M$-15.48M$-41.34M$-69.99M$-77.39M$-14.95M$-31.66M$-20.91M
EBITDA margin-944.0%-3224.5%-8611.8%-687.8%-832.8%-82.5%-30680.5%-272.6%
EBIT$-15.18M$-16.29M$-42.20M$-71.11M$-78.82M$-16.16M$-32.59M$-21.49M
Interest expense$91085.00$138096.00$202165.00$363762.00$693323.00$1.11M$851874.00$463132.00
Income tax$-547003.00$861572.00$3164.00$1.70M$459055.00$1.69M$-17553.00
Effective tax rate3.6%-5.2%-0.0%-2.4%-0.6%-9.8%0.1%0.0%
Net income$-14.72M$-17.29M$-16.44M$-73.18M$-79.97M$-18.95M$-33.42M$-17.61M
Net income growth (YoY)-17.5%+5.0%-345.2%-9.3%+76.3%-76.4%+47.3%
Profit margin-974.0%-3602.9%-3424.1%-719.2%-860.6%-104.6%-32386.4%-229.6%